Posted in | News

Avago Technologies Demonstrates 20 Gbps SerDes Performance in 40nm CMOS Technology

Avago Technologies today announced that it has demonstrated 20 Gbps SerDes performance in 40nm CMOS technology. Continuing its legacy of embedded SerDes leadership, Avago’s 40nm cores represent its seventh generation of high performance SerDes IP. With over 60 million SerDes channels shipped, Avago has a proven history of delivering reliable, high-performance ASICs and now achieves another milestone by measuring 20 Gbps SerDes in TSMC’s 40 nm CMOS process.

Ideal for data center applications, the embedded SerDes technology will support a broad range of standards, such as PCI Express, Fibre Channel, XAUI, CEI-11G, XFI, 802.3ap (KR), and SFI and is suitable for chip-to-chip, board-to-board, chasis-to-chasis, and backplane implementations. Inherently flexible due to its modular architecture and multi-rate capability, Avago’s SerDes IP also offers power management options which are vital in today’s energy-sensitive data center environments.

“Avago’s ongoing leadership in embedded SerDes has enabled our steady growth in the networking, storage, and computing markets,” said Frank Ostojic, vice president and general manager of Avago Technologies’ ASIC products division. “With our early demonstration of SerDes IP in leading-edge CMOS technology, Avago can enable our customers to meet the speed, throughput, and power requirements that their marketplaces demand.”

“Avago and TSMC have had a decades-long relationship marked by Avago’s early introduction of key IP in advanced processes,” said Rick Cassidy, President, TSMC North America. “The ongoing cooperation and collaboration between our companies has resulted in a history of success, reflected most recently by Avago’s achievement in our 40G process.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.